Cargando…

Identification of HPV16 E1 and E2-specific T cells in the oropharyngeal cancer tumor microenvironment

BACKGROUND: High-risk human papillomavirus (HPV) is a primary cause of an increasing number of oropharyngeal squamous cell carcinomas (OPSCCs). The viral etiology of these cancers provides the opportunity for antigen-directed therapies that are restricted in scope compared with cancers without viral...

Descripción completa

Detalles Bibliográficos
Autores principales:	McInnis, Christine, Bhatia, Shilpa, Vijaykumar, Brinda, Tian, Qiaomu, Sun, Yanbo, Leistritz-Edwards, Del, Quinn, Charles T, Uppaluri, Ravi, Egloff, Ann Marie, Srinivasan, Lakshmi, Pregibon, Daniel C, Coyle, Anthony J, Hanna, Glenn J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Basic Tumor Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069587/ https://www.ncbi.nlm.nih.gov/pubmed/36990508 http://dx.doi.org/10.1136/jitc-2023-006721

Ejemplares similares

Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens
por: Arribillaga, Laura, et al.
Publicado: (2020)

Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV‐related oropharyngeal cancer and cancer of unknown primary
por: Tanaka, Hidenori, et al.
Publicado: (2021)

Is HPV‐Associated Oropharyngeal Cancer Becoming More Common in Older Patients?
por: Thompson, James D., et al.
Publicado: (2018)

Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer
por: Travelli, Cristina, et al.
Publicado: (2023)

TP53 gain-of-function mutation modulates the immunosuppressive microenvironment in non-HPV-associated oral squamous cell carcinoma
por: Shi, Yewen, et al.
Publicado: (2023)

The role of the innate and adaptive immune response in HPV‐associated oropharyngeal squamous cell carcinoma
por: Subbarayan, Rahul Sridhar, et al.
Publicado: (2019)

CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors
por: Duurland, Chantal L, et al.
Publicado: (2022)

Comparison of PI3K Pathway in HPV‐Associated Oropharyngeal Cancer With and Without Tobacco Exposure
por: Kiessling, Si‐Young, et al.
Publicado: (2018)

Preconditioning of the immune system modulates the response of papillary thyroid cancer to immune checkpoint inhibitors
por: Pani, Fabiana, et al.
Publicado: (2022)

The combined HPV16-E2/E6/E7 T cell response in oropharyngeal cancer predicts superior survival
por: Santegoets, Saskia J., et al.
Publicado: (2023)

DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft Rejection
por: Chandra, Janin, et al.
Publicado: (2017)

DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma
por: Fitzgerald, Allison A, et al.
Publicado: (2021)

HPV16 E6 seropositivity and oropharyngeal cancer: Marker of exposure, risk, or disease?
por: Landy, Rebecca, et al.
Publicado: (2021)

Immunization with short peptide particles reveals a functional CD8(+) T-cell neoepitope in a murine renal carcinoma model
por: He, Xuedan, et al.
Publicado: (2021)

Metastatic model of HPV+ oropharyngeal squamous cell carcinoma demonstrates heterogeneity in tumor metastasis
por: Vermeer, Daniel W., et al.
Publicado: (2016)

HPV-related oropharyngeal cancer prevalence in a middle eastern population using E6/E7 PCR
por: Maroun, Christopher A., et al.
Publicado: (2020)

Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma
por: Simonds, Erin F, et al.
Publicado: (2021)

HPV-Induced Oropharyngeal Cancer and the Role of the E7 Oncoprotein Detection via Brush Test
por: Borena, Wegene, et al.
Publicado: (2020)

Characterisation of anal intraepithelial neoplasia and anal cancer in HIV‐positive men by immunohistochemical markers p16, Ki‐67, HPV‐E4 and DNA methylation markers
por: van der Zee, Ramon P., et al.
Publicado: (2021)

Commentary: Laser Interstitial Thermal Therapy for First-Line Treatment of Surgically Accessible Recurrent Glioblastoma: Outcomes Compared With a Surgical Cohort
por: Schwalb, Allison M., et al.
Publicado: (2022)

Impact of HPV in Oropharyngeal Cancer
por: Marklund, Linda, et al.
Publicado: (2011)

HPV Status and second primary tumours in Oropharyngeal Squamous Cell Carcinoma
por: Xu, Caroline C, et al.
Publicado: (2013)

The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients
por: Taberna, Miren, et al.
Publicado: (2018)

Serum HPV16 E7 Oncoprotein Is a Recurrence Marker of Oropharyngeal Squamous Cell Carcinomas
por: Oton-Gonzalez, Lucia, et al.
Publicado: (2021)

HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study
por: Economopoulou, Panagiota, et al.
Publicado: (2019)

Treatment failure patterns are similar between p16− and p16+ oropharyngeal squamous cell carcinomas
por: Hamill, Chelsea S., et al.
Publicado: (2022)

Sensitive HPV detection in oropharyngeal cancers
por: Winder, David M, et al.
Publicado: (2009)

The immune response in HPV(+) oropharyngeal cancer
por: King, Emma V, et al.
Publicado: (2014)

Immunotherapy in HPV-Related Oropharyngeal Cancers
por: Roof, Logan, et al.
Publicado: (2023)

HPV-mediated oropharyngeal carcinogenesis: An overview
por: Patil†, Shankargouda
Publicado: (2022)

HPV+ Oropharyngeal Cancer in Waldenström Macroglobulinemia
por: Raslan, Shahm, et al.
Publicado: (2023)

CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy
por: Wang, Hongfei, et al.
Publicado: (2020)

Regulation of tumor growth by leukocyte-specific protein 1 in T cells
por: Kwon, Riri, et al.
Publicado: (2020)

IL-31 induces antitumor immunity in breast carcinoma
por: Kan, Tal, et al.
Publicado: (2020)

IFN-γ treatment protocol for MHC-I(lo)/PD-L1(+) pancreatic tumor cells selectively restores their TAP-mediated presentation competence and CD8 T-cell priming potential
por: Stifter, Katja, et al.
Publicado: (2020)

Combining IL-2-based immunotherapy with commensal probiotics produces enhanced antitumor immune response and tumor clearance
por: Shi, Linlin, et al.
Publicado: (2020)

2,5-dimethylcelecoxib improves immune microenvironment of hepatocellular carcinoma by promoting ubiquitination of HBx-induced PD-L1
por: Chen, Zhanfei, et al.
Publicado: (2020)

Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy
por: Bao, Xuanwen, et al.
Publicado: (2020)

Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions
por: Russick, Jules, et al.
Publicado: (2020)

Breast cancer-induced immune suppression in the sentinel lymph node is effectively countered by CpG-B in conjunction with inhibition of the JAK2/STAT3 pathway
por: van Pul, Kim M, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8m3t0llaj2rai1vno3oite0vpc